Curtis Dobson has been shortlisted in the Commercial Innovator section for his serial innovations focusing on the treatment or detection of infectious agents on medical device surfaces.
He joins Neil Gibbs and Catherine O’Neill, from the Faculty of Medical and Human Science’s Institute of Inflammation and Repair, who have been shortlisted in the same category for their novel approaches to safe skin healthcare – Curapel.
The innovators will be competing to be crowned Innovator of the Year 2014 at a high-profile event in London on 20 March 2014 in recognition of their efforts to take their innovation beyond the lab to deliver social and economic benefits.
The other categories include Social Innovator and Most Promising Innovator reflecting the breadth of the benefits delivered by BBSRC’s investment in UK bioscience. One of the category winners will then be chosen as the overall Innovator of the Year.
Winners in each category will receive a £15,000 award for them to support their research, training or other activities promoting economic or social impact. The overall winner will receive a further £15,000.
The finalists will be judged by an expert independent panel. The judges will be looking to recognise those innovators who have worked the hardest and gone the furthest to take their science out of the lab to deliver impact.
Innovator of the Year is one of BBSRC’s Fostering Innovation competitions that aim to promote excellence amongst researchers, knowledge exchange practitioners, departments and institutions by recognising successful approaches to innovation and impact in the biosciences.
More information about Innovator of the Year can be found on the BBSRC website.